<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are clonal disorders characterized by ineffective hematopoiesis and subsequent frequent development of <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>In children and adolescents, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> are uncommon disorders, accounting for less than 5% of <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancy</z:e>, with great <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in presentation and clinical course </plain></SENT>
<SENT sid="2" pm="."><plain>The genetic changes predisposing children to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> are largely obscure </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0004026'>Monosomy</z:mp> 7 is the most common chromosomal abnormality, often occurring as a sole abnormality </plain></SENT>
<SENT sid="4" pm="."><plain>The recent pediatric modification of the World Health Organization (WHO) classification has greatly facilitated the diagnostic process </plain></SENT>
<SENT sid="5" pm="."><plain>Refractory cytopenia (RC) is the most common <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> subtype in children, occurring in about half of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cases </plain></SENT>
<SENT sid="6" pm="."><plain>There is consensus that the relationship between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with increased blast count and de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> is better defined by biological and clinical features than by blast count </plain></SENT>
<SENT sid="7" pm="."><plain>Because <z:mp ids='MP_0004026'>monosomy</z:mp> 7 is the only chromosomal abnormality strongly suggestive of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, children presenting with a low blast count and other chromosomal aberrations or <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype must be closely observed before a diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> can be established </plain></SENT>
<SENT sid="8" pm="."><plain>With an increasing number of children surviving primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> with chemotherapy or radiation therapy, the incidence of secondary <z:e sem="disease" ids="C1292780" disease_type="Neoplastic Process" abbrv="">therapy-related MDS</z:e> is rising </plain></SENT>
<SENT sid="9" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> risk is also increased in patients with inherited <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> disorders; this relationship provides valuable insights into <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> biology </plain></SENT>
<SENT sid="10" pm="."><plain>Allogeneic hematopoietic stem cell transplantation (HSCT) from a matched related or suitable unrelated donor is the choice for most children with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and can rescue a large proportion of patients </plain></SENT>
</text></document>